| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.71 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |